Ryght, an innovator in generative AI (GenAI) technology for life science companies, today announced the launch of their namesake platform, Ryght.  Designed with security at the forefront, Ryght is an enterprise-grade platform that enables companies to develop and deploy GenAI applications to their teams privately. Leveraging industry-specific knowledge from biomedical literature and a continuously expanding database of medical records, Ryght accelerates work in scientific research, clinical operations, and commercialization to provide actionable knowledge and informed decision-making to life science companies. Read More